Related Experiment Video
Updated: May 22, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Ethical issues in Alzheimer's disease: an overview
Antoine Leuzy1, Serge Gauthier
1McGill Centre for Studies in Aging, Douglas Mental Health University Institute, Montreal, QC, Canada. antoine.leuzy@mail.mcgill.ca
Expert Review of Neurotherapeutics
|May 4, 2012
Summary
Ethical considerations in Alzheimer's disease (AD) evolve with diagnosis, genetics, and treatment stages. Early diagnosis and new therapies present unique challenges for patients and caregivers, necessitating updated ethical guidelines.
Area of Science:
- Neuroscience
- Gerontology
- Medical Ethics
Background:
- Alzheimer's disease (AD) is the leading cause of dementia, presenting complex ethical dilemmas.
- Diagnostic criteria are shifting towards earlier detection, even in pre-dementia stages.
- Genetic factors, including APOE, and rare mutations influence AD risk and testing debates.
Purpose of the Study:
- To review the evolving ethical issues in Alzheimer's disease management.
- To discuss the implications of early diagnosis and genetic testing.
- To examine current and future therapeutic and care strategies.
Main Methods:
- Literature review of ethical considerations in Alzheimer's disease.
- Analysis of diagnostic guideline revisions and genetic testing implications.
- Evaluation of current symptomatic treatments and future drug development.
Main Results:
- Early AD diagnosis raises ethical concerns regarding patient insight and prognosis disclosure.
- Genetic testing for AD risk factors like APOE is debated but may be crucial for new treatments.
- Current treatments have limitations, influencing clinical trial designs and access.
- Management of driving cessation, restraint use, and end-of-life care requires standardized approaches.
Conclusions:
- Ethical challenges in AD are multifaceted, evolving with disease stage and scientific advancements.
- Future treatments necessitate careful consideration of stopping rules and ethical implementation.
- A palliative care approach is increasingly relevant for end-of-life management in AD.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:27Ethical Issues
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...